These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5502909)

  • 1. [Value of Encephabol in child neuropsychiatry].
    Dubois B; Balmelle J; Fontaine G
    Lille Med; 1970 Nov; ():Suppl 6:1348+. PubMed ID: 5502909
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical data on a drug with a base of gamma-aminobutyric acid and vitamin B6 in the treatment of cerebral paralysis, oligophrenia and behavior disorders in children].
    Hoineff S
    Hospital (Rio J); 1968 May; 73(5):1653-7. PubMed ID: 5308767
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of treatment with Encephabol juice in pediatrics].
    Neu W
    Landarzt; 1967 Sep; 43(25):1226-7. PubMed ID: 5610716
    [No Abstract]   [Full Text] [Related]  

  • 4. [The GABOB in pediatric neuropsychiatry. Indications and results].
    Cavazzuti GB
    Clin Ter; 1969 Mar; 48(6):515-24. PubMed ID: 5404652
    [No Abstract]   [Full Text] [Related]  

  • 5. [Trial of UCB (piracetam) 6215 in infantile (and adult) neuropsychiatry].
    Lafon R; Pouget R; Chiariny JF; Bertier JF; Darius J
    Ann Med Psychol (Paris); 1972; 2(3):425-31. PubMed ID: 4648231
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trial of sulpiride in child psychiatry].
    Kohler C; Marcon G; Maritan C
    Rev Neuropsychiatr Infant; 1971 Dec; 19(12):751-8. PubMed ID: 5138771
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dipiperon treatment in a psychiatric out-patient clinic for children and youths].
    Müller-Küppers M
    Acta Paedopsychiatr; 1971; 38(2):40-6. PubMed ID: 4942603
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sulpyride use in a child psychiatric department].
    Pallegroix M; Chavanne J
    Rev Neuropsychiatr Infant; 1973 Jun; 21(6):379-83. PubMed ID: 4713455
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of clinical and encephalographic action of 1035 MD in child neuropsychiatry. Apropos of 33 cases followed during a year].
    Savelli A; Rigal J
    Rev Neuropsychiatr Infant; 1974 Mar; 22(3):199-205. PubMed ID: 4841032
    [No Abstract]   [Full Text] [Related]  

  • 10. Breath-holding spells and vitamin B6.
    Abecasis MK
    Dev Med Child Neurol; 1973 Aug; 15(4):541. PubMed ID: 4732908
    [No Abstract]   [Full Text] [Related]  

  • 11. Pilot study with RO 5-4556 in emotionally disturbed retarded children.
    Ucer E
    Curr Ther Res Clin Exp; 1968 Apr; 10(4):187-95. PubMed ID: 4967223
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the clinical effects of sulpiride in medico-pedgogic day-school and day hospital for children].
    Lang JL; Le Strat M
    Rev Neuropsychiatr Infant; 1971 Dec; 19(12):759-72. PubMed ID: 5138772
    [No Abstract]   [Full Text] [Related]  

  • 13. Isofloxythepin in restless oligophrenic children.
    Zapletálek M; Hametová M; Rýdlová E
    Act Nerv Super (Praha); 1989 Dec; 31(4):265. PubMed ID: 2576920
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavior disorders in mental retardates. Treatment with thioridazine has proved to be an important part of the management of these patients.
    Connolly JR
    Pa Med; 1968 Jun; 71(6):67-9. PubMed ID: 5649376
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
    Madrid AL; State MW; King BH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action of benzperidol (8089 CB oral solution, at doses of 0.2 mg-ml) on behavior disorders in a group of children followed in a service for profound deficiency].
    Schmidt M; Daudet G
    Ann Med Psychol (Paris); 1968 Jan; 1(1):113-9. PubMed ID: 5651938
    [No Abstract]   [Full Text] [Related]  

  • 17. [Unfavorable effects of neuro- and psycho-active drugs in the infantile age].
    Gambaro C
    Fracastoro; 1971; 64(1):45-50. PubMed ID: 5093367
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychotropic drug therapy in children and adolescents.
    Abdou FA
    Va Med Mon (1918); 1967 Aug; 94(8):464-7. PubMed ID: 6074610
    [No Abstract]   [Full Text] [Related]  

  • 19. The biochemical and clinical effect of pyridoxine in children with brain disorders.
    Heeley AF; Piesowicz AT; McCubbing DG
    Clin Sci; 1968 Oct; 35(2):381-9. PubMed ID: 5721240
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of pyritinol in the treatment of mentally retarded children. Trials in a medicopedagogic institut].
    Hugonenq H; Espinas A; Saias
    Rev Neuropsychiatr Infant; 1974; 22(1):133-9. PubMed ID: 4822231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.